Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

NCT02979470 is registered in ClinicalTrials.gov with AC Camargo Cancer Center as lead sponsor.

NCT NCT02979470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02979470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers
Lead sponsor
AC Camargo Cancer Center
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2019
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer stage iib, colon cancer stage iiia, colon cancer stage iiib, colon cancer stage iiic, rectum cancer, adenocarcinoma